{"transactions":[{"id":736267,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T22:25:30.000Z","date":"2026-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5415,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a \"Company Stock Option\") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a \"Company Stock Option\") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a \"Company Stock Option\") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":9.2565,"underlying":"Common Stock","underlying_shares":5415},"source":{"system":"sec-edgar","filing":"0001104659-26-074739","document":"tm2618077-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465926074739/tm2618077-2_4seq1.xml","form_type":"4"}},{"id":736266,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T22:25:30.000Z","date":"2026-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5415,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a \"Company Stock Option\") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a \"Company Stock Option\") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a \"Company Stock Option\") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":15.15,"underlying":"Common Stock","underlying_shares":5415},"source":{"system":"sec-edgar","filing":"0001104659-26-074739","document":"tm2618077-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465926074739/tm2618077-2_4seq1.xml","form_type":"4"}},{"id":736265,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T22:25:30.000Z","date":"2026-06-16","kind":"other","planned":false,"acquired":false,"shares":11420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of May 13, 2026, by and among Assertio Holdings, Inc. (the \"Issuer\"), Zydus Worldwide DMCC (\"Parent\"), Zara Merger Sub Inc., a wholly owned subsidiary of Parent (\"Purchaser\") and Zydus Pharmaceuticals (USA) Inc., pursuant to which Purchaser completed a tender offer (the \"Offer\") for all outstanding shares of common stock of the Issuer (\"Company Common Stock\") at a price of $23.50 per share in cash, without interest (the \"Offer Price\"), and thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\"), effective as of June 16, 2026 (the \"Effective Time\"). At the Effective Time, each issued and outstanding share of Company Common Stock was cancelled and converted into the right [continues to Footnote 2]"},{"field":"shares","element":"transactionShares","label":"F2","text":"[continues from Footnote 1] to receive the Offer Price, less any applicable withholding taxes."},{"field":"shares","element":"transactionShares","label":"F3","text":"Pursuant to the Merger Agreement, each restricted stock unit of the Issuer (each, a \"Company RSU\") that was outstanding but unvested immediately prior to the Effective Time became fully vested as of immediately prior to the Effective Time and, at the Effective Time, each outstanding Company RSU was cancelled and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-074739","document":"tm2618077-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465926074739/tm2618077-2_4seq1.xml","form_type":"4"}},{"id":790003,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-06T22:06:44.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":4851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that (1) vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting, and (2) were granted on the date of the Issuer's 2026 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 26, 2025, the Issuer effected a 1-for-15 reverse stock split (the \"Reverse Stock Split\"). The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":11420,"source":{"system":"sec-edgar","filing":"0001104659-26-056418","document":"tm2613761-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465926056418/tm2613761-5_4seq1.xml","form_type":"4"}},{"id":1002096,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-12T23:00:15.000Z","date":"2025-11-10","kind":"sale","planned":true,"acquired":false,"shares":8959,"price":0.7597,"value":6806.1523,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sale price. The shares were sold in multiple same-way transactions on November 10, 2025, at prices ranging from $0.7544 to $0.7668 per share of common stock. If requested by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares of common stock sold at each separate price."}],"balance_after":98541,"source":{"system":"sec-edgar","filing":"0001104659-25-110557","document":"tm2530939-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465925110557/tm2530939-1_4seq1.xml","form_type":"4"}},{"id":1153834,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-09T22:03:04.000Z","date":"2025-05-07","kind":"grant","planned":false,"acquired":true,"shares":81225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for these derivative securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock Options that (1) vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting, and (2) were granted on the date of the Issuer's 2025 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy."}],"balance_after":81225,"derivative":{"exercise_price":0.6171,"expiration_date":"2035-05-07","underlying":"Common Stock","underlying_shares":81225},"source":{"system":"sec-edgar","filing":"0001104659-25-046870","document":"tm2514518-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465925046870/tm2514518-5_4seq1.xml","form_type":"4"}},{"id":1153833,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-09T22:03:04.000Z","date":"2025-05-07","kind":"grant","planned":false,"acquired":true,"shares":53750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that (1) vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting, and (2) were granted on the date of the Issuer's 2025 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy."}],"balance_after":107500,"source":{"system":"sec-edgar","filing":"0001104659-25-046870","document":"tm2514518-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465925046870/tm2514518-5_4seq1.xml","form_type":"4"}},{"id":1369107,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-11-12T23:01:08.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":81225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for these derivative securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options were granted on the date of Mr. Stark's initial appointment to the Issuer's Board of Directors in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy. One-third of these stock options are scheduled to vest on each of November 7, 2025, 2026 and 2027, assuming continued service through the applicable vesting date."}],"balance_after":81225,"derivative":{"exercise_price":1.01,"expiration_date":"2034-11-07","underlying":"Common Stock","underlying_shares":81225},"source":{"system":"sec-edgar","filing":"0001104659-24-116977","document":"tm2428139-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465924116977/tm2428139-2_4seq1.xml","form_type":"4"}},{"id":1369106,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-12T23:01:08.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":53750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units were granted on the date of Mr. Stark's initial appointment to the Issuer's Board of Directors in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy. One-third of these restricted stock units are scheduled to vest on each of November 7, 2025, 2026 and 2027, assuming continued service through the applicable vesting date."}],"balance_after":53750,"source":{"system":"sec-edgar","filing":"0001104659-24-116977","document":"tm2428139-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465924116977/tm2428139-2_4seq1.xml","form_type":"4"}},{"id":1964386,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-08T21:05:34.000Z","date":"2023-03-07","kind":"sale","acquired":false,"shares":49475,"price":9.4279,"value":466445.3525,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.37 to $9.725, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2974.39,"source":{"system":"sec-edgar","filing":"0001209191-23-017161","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123017161/doc4.xml","form_type":"4"}},{"id":1964385,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-08T21:05:34.000Z","date":"2023-03-06","kind":"sale","acquired":false,"shares":16491,"price":9.9309,"value":163770.4719,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.86 to $10.045, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":52449.39,"source":{"system":"sec-edgar","filing":"0001209191-23-017161","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123017161/doc4.xml","form_type":"4"}},{"id":1967258,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2023-03-07T21:14:08.000Z","date":"2023-03-05","kind":"exercise","acquired":false,"shares":20199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 5, 2021, with 20,199 vested on each of March 5, 2022 and March 5, 2023, 20,199 vesting on March 5, 2024, and 20,201 vesting on March 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 5, 2021, with 20,199 vested on each of March 5, 2022 and March 5, 2023, 20,199 vesting on March 5, 2024, and 20,201 vesting on March 5, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":40400,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20199},"source":{"system":"sec-edgar","filing":"0001209191-23-016721","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016721/doc4.xml","form_type":"4"}},{"id":1967257,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2023-03-07T21:14:08.000Z","date":"2023-03-04","kind":"exercise","acquired":false,"shares":31836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 4, 2022, with 31,836 vested on March 4, 2023, 31,836 vesting on each of March 4, 2024 and March 4, 2025 and 31,837 vesting on March 4, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 4, 2022, with 31,836 vested on March 4, 2023, 31,836 vesting on each of March 4, 2024 and March 4, 2025 and 31,837 vesting on March 4, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":95509,"derivative":{"underlying":"Ordinary Shares","underlying_shares":31836},"source":{"system":"sec-edgar","filing":"0001209191-23-016721","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016721/doc4.xml","form_type":"4"}},{"id":1967256,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2023-03-07T21:14:08.000Z","date":"2023-03-04","kind":"exercise","acquired":false,"shares":13931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 4, 2019, with 13,930 vested on each of March 4, 2021 and March 4, 2022, and 13,931 vested on March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 4, 2019, with 13,930 vested on each of March 4, 2021 and March 4, 2022, and 13,931 vested on March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":13931},"source":{"system":"sec-edgar","filing":"0001209191-23-016721","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016721/doc4.xml","form_type":"4"}},{"id":1967255,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2023-03-07T21:14:08.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":94621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on March 3, 2023, with 23,655 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 23,656 vesting on March 3, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on March 3, 2023, with 23,655 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 23,656 vesting on March 3, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":94621,"derivative":{"underlying":"Ordinary Shares","underlying_shares":94621},"source":{"system":"sec-edgar","filing":"0001209191-23-016721","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016721/doc4.xml","form_type":"4"}},{"id":1967254,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-07T21:14:08.000Z","date":"2023-03-05","kind":"exercise","acquired":true,"shares":20199,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":68940.39,"source":{"system":"sec-edgar","filing":"0001209191-23-016721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016721/doc4.xml","form_type":"4"}},{"id":1967253,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-07T21:14:08.000Z","date":"2023-03-04","kind":"exercise","acquired":true,"shares":31836,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":48741.39,"source":{"system":"sec-edgar","filing":"0001209191-23-016721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016721/doc4.xml","form_type":"4"}},{"id":1967252,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-07T21:14:08.000Z","date":"2023-03-04","kind":"exercise","acquired":true,"shares":13931,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":16905.39,"source":{"system":"sec-edgar","filing":"0001209191-23-016721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016721/doc4.xml","form_type":"4"}},{"id":1981795,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2023-03-02T12:38:31.000Z","date":"2023-02-28","kind":"exercise","acquired":false,"shares":44953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 7, 2023 pursuant to the satisfaction of performance criteria and vested on February 28, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 7, 2023 pursuant to the satisfaction of performance criteria and vested on February 28, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":44953},"source":{"system":"sec-edgar","filing":"0001209191-23-014442","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123014442/doc4.xml","form_type":"4"}},{"id":1981794,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2023-03-02T12:38:31.000Z","date":"2023-02-28","kind":"exercise","acquired":false,"shares":18430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on February 28, 2020 with 18,430 vested on each of February 28, 2021, February 28, 2022 and February 28, 2023, and 18,430 vesting on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on February 28, 2020 with 18,430 vested on each of February 28, 2021, February 28, 2022 and February 28, 2023, and 18,430 vesting on February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":18430,"derivative":{"underlying":"Ordinary Shares","underlying_shares":18430},"source":{"system":"sec-edgar","filing":"0001209191-23-014442","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123014442/doc4.xml","form_type":"4"}},{"id":1981793,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-02T12:38:31.000Z","date":"2023-02-28","kind":"sale","acquired":false,"shares":44953,"price":9.8866,"value":444432.3298,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.86 to $9.94, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2974.39,"source":{"system":"sec-edgar","filing":"0001209191-23-014442","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123014442/doc4.xml","form_type":"4"}},{"id":1981792,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-02T12:38:31.000Z","date":"2023-02-28","kind":"exercise","acquired":true,"shares":44953,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":47927.39,"source":{"system":"sec-edgar","filing":"0001209191-23-014442","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123014442/doc4.xml","form_type":"4"}},{"id":1981791,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-02T12:38:31.000Z","date":"2023-02-28","kind":"sale","acquired":false,"shares":18430,"price":9.8866,"value":182210.038,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.86 to $9.94, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2974.39,"source":{"system":"sec-edgar","filing":"0001209191-23-014442","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123014442/doc4.xml","form_type":"4"}},{"id":1981790,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-02T12:38:31.000Z","date":"2023-02-28","kind":"exercise","acquired":true,"shares":18430,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":21404.39,"source":{"system":"sec-edgar","filing":"0001209191-23-014442","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123014442/doc4.xml","form_type":"4"}},{"id":2025606,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2023-02-09T12:06:06.000Z","date":"2023-02-07","kind":"grant","acquired":true,"shares":44953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on February 28, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on February 28, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":44953,"derivative":{"underlying":"Ordinary Shares","underlying_shares":44953},"source":{"system":"sec-edgar","filing":"0001209191-23-007954","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123007954/doc4.xml","form_type":"4"}},{"id":2200569,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2022-07-29T11:02:19.000Z","date":"2022-07-28","kind":"sale","acquired":false,"shares":58163,"price":9.0365,"value":525589.9495,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.035 to\n$9.04, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full\ninformation regarding the number of shares sold at each separate price."}],"balance_after":2974.39,"source":{"system":"sec-edgar","filing":"0001209191-22-043422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122043422/doc4.xml","form_type":"4"}},{"id":2345953,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2022-03-08T21:13:37.000Z","date":"2022-03-05","kind":"exercise","acquired":false,"shares":20199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Restricted share units were granted on March 5, 2021, with 20,199 having vested on March 5, 2022, 20,199 vesting on each of March 5, 2023 and March 5, 2024, and\n20,201 vesting on March 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Restricted share units were granted on March 5, 2021, with 20,199 having vested on March 5, 2022, 20,199 vesting on each of March 5, 2023 and March 5, 2024, and\n20,201 vesting on March 5, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":60599,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20199},"source":{"system":"sec-edgar","filing":"0001209191-22-017063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017063/doc4.xml","form_type":"4"}},{"id":2345952,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2022-03-08T21:13:37.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":127345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Restricted share units were granted on March 4, 2022, with 31,836 vesting on each of March 4, 2023, March 4, 2024 and March 4, 2025, and 31,837 vesting on March 4, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Restricted share units were granted on March 4, 2022, with 31,836 vesting on each of March 4, 2023, March 4, 2024 and March 4, 2025, and 31,837 vesting on March 4, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":127345,"derivative":{"underlying":"Ordinary Shares","underlying_shares":127345},"source":{"system":"sec-edgar","filing":"0001209191-22-017063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017063/doc4.xml","form_type":"4"}},{"id":2345951,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2022-03-08T21:13:37.000Z","date":"2022-03-04","kind":"exercise","acquired":false,"shares":13930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Restricted share units were granted on March 4, 2019, with 13,930 having vested on each of March 4, 2021 and March 4, 2022, and 13,931 vesting on March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Restricted share units were granted on March 4, 2019, with 13,930 having vested on each of March 4, 2021 and March 4, 2022, and 13,931 vesting on March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":13931,"derivative":{"underlying":"Ordinary Shares","underlying_shares":13930},"source":{"system":"sec-edgar","filing":"0001209191-22-017063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017063/doc4.xml","form_type":"4"}},{"id":2345950,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2022-03-08T21:13:37.000Z","date":"2022-03-04","kind":"exercise","acquired":false,"shares":37939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were received on February 8, 2022 upon satisfaction of performance criteria and vested on March 4, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were received on February 8, 2022 upon satisfaction of performance criteria and vested on March 4, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":37939},"source":{"system":"sec-edgar","filing":"0001209191-22-017063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017063/doc4.xml","form_type":"4"}},{"id":2345949,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-08T21:13:37.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":9057,"price":7.3667,"value":66720.2019,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting\nof the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.30 to $7.49, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":61137.39,"source":{"system":"sec-edgar","filing":"0001209191-22-017063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017063/doc4.xml","form_type":"4"}},{"id":2345948,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-08T21:13:37.000Z","date":"2022-03-05","kind":"exercise","acquired":true,"shares":20199,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":70194.39,"source":{"system":"sec-edgar","filing":"0001209191-22-017063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017063/doc4.xml","form_type":"4"}},{"id":2345947,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-08T21:13:37.000Z","date":"2022-03-04","kind":"sale","acquired":false,"shares":6246,"price":7.4825,"value":46735.695,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting\nof the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.40 to $7.60, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":49995.39,"source":{"system":"sec-edgar","filing":"0001209191-22-017063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017063/doc4.xml","form_type":"4"}},{"id":2345946,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-08T21:13:37.000Z","date":"2022-03-04","kind":"exercise","acquired":true,"shares":13930,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":56241.39,"source":{"system":"sec-edgar","filing":"0001209191-22-017063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017063/doc4.xml","form_type":"4"}},{"id":2345945,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-08T21:13:37.000Z","date":"2022-03-04","kind":"sale","acquired":false,"shares":17008,"price":7.4825,"value":127262.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting\nof the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.40 to $7.60, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":42311.39,"source":{"system":"sec-edgar","filing":"0001209191-22-017063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017063/doc4.xml","form_type":"4"}},{"id":2345944,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-08T21:13:37.000Z","date":"2022-03-04","kind":"exercise","acquired":true,"shares":37939,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":59319.39,"source":{"system":"sec-edgar","filing":"0001209191-22-017063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017063/doc4.xml","form_type":"4"}},{"id":2363048,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2022-03-02T12:54:31.000Z","date":"2022-02-28","kind":"exercise","acquired":false,"shares":18430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 28, 2020, with 18,430 having vested on each of February 28, 2021 and February 28, 2022, and\n18,430 vesting on each of February 28, 2023 and February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 28, 2020, with 18,430 having vested on each of February 28, 2021 and February 28, 2022, and\n18,430 vesting on each of February 28, 2023 and February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":36860,"derivative":{"underlying":"Ordinary Shares","underlying_shares":18430},"source":{"system":"sec-edgar","filing":"0001209191-22-014475","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122014475/doc4.xml","form_type":"4"}},{"id":2363047,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-02T12:54:31.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":6452,"price":8.1422,"value":52533.4744,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting\nof the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.035 to $8.255,\ninclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full\ninformation regarding the number of shares sold at each separate price."}],"balance_after":21380.39,"source":{"system":"sec-edgar","filing":"0001209191-22-014475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122014475/doc4.xml","form_type":"4"}},{"id":2363046,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-02T12:54:31.000Z","date":"2022-02-28","kind":"exercise","acquired":true,"shares":18430,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":27832.39,"source":{"system":"sec-edgar","filing":"0001209191-22-014475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122014475/doc4.xml","form_type":"4"}},{"id":2405272,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2022-02-10T21:13:45.000Z","date":"2022-02-08","kind":"grant","acquired":true,"shares":37939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to\ntime-based vesting and will vest on March 4, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to\ntime-based vesting and will vest on March 4, 2022."}],"balance_after":37939,"derivative":{"underlying":"Ordinary Shares","underlying_shares":37939},"source":{"system":"sec-edgar","filing":"0001209191-22-008418","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122008418/doc4.xml","form_type":"4"}},{"id":2405271,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2022-02-10T21:13:45.000Z","date":"2022-02-09","kind":"exercise","acquired":false,"shares":12538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 9, 2018, with 12,538 having vested on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 9, 2018, with 12,538 having vested on each of February 9, 2020, February 9, 2021 and February 9, 2022."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12538},"source":{"system":"sec-edgar","filing":"0001209191-22-008418","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122008418/doc4.xml","form_type":"4"}},{"id":2405270,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2022-02-10T21:13:45.000Z","date":"2022-02-09","kind":"sale","acquired":false,"shares":6110,"price":9.0602,"value":55357.822,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting\nof the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.06 to $9.075, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":9402.39,"source":{"system":"sec-edgar","filing":"0001209191-22-008418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122008418/doc4.xml","form_type":"4"}},{"id":2405269,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2022-02-10T21:13:45.000Z","date":"2022-02-09","kind":"exercise","acquired":true,"shares":12538,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":15512.39,"source":{"system":"sec-edgar","filing":"0001209191-22-008418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122008418/doc4.xml","form_type":"4"}},{"id":2715442,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2021-05-13T11:48:38.000Z","date":"2021-05-11","kind":"exercise","acquired":false,"shares":37884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on February 9, 2021 pursuant to the satisfaction of performance criteria and vested on May 11, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on February 9, 2021 pursuant to the satisfaction of performance criteria and vested on May 11, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":37884},"source":{"system":"sec-edgar","filing":"0001209191-21-032254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121032254/doc4.xml","form_type":"4"}},{"id":2715441,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-13T11:48:38.000Z","date":"2021-05-11","kind":"sale","acquired":false,"shares":37884,"price":10.2187,"value":387125.2308,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.205 to $10.230, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2974.39,"source":{"system":"sec-edgar","filing":"0001209191-21-032254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121032254/doc4.xml","form_type":"4"}},{"id":2715440,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-13T11:48:38.000Z","date":"2021-05-11","kind":"exercise","acquired":true,"shares":37884,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":40858.39,"source":{"system":"sec-edgar","filing":"0001209191-21-032254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121032254/doc4.xml","form_type":"4"}},{"id":2804342,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2021-03-08T21:12:50.000Z","date":"2021-03-05","kind":"grant","acquired":true,"shares":80798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 5, 2021, with 20,199 vesting on each of March 5, 2022, March 5, 2023, March 5, 2024, and 20,201 vesting on March 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 5, 2021, with 20,199 vesting on each of March 5, 2022, March 5, 2023, March 5, 2024, and 20,201 vesting on March 5, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":80798,"derivative":{"underlying":"Ordinary Shares","underlying_shares":80798},"source":{"system":"sec-edgar","filing":"0001209191-21-018534","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121018534/doc4.xml","form_type":"4"}},{"id":2804341,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2021-03-08T21:12:50.000Z","date":"2021-03-04","kind":"exercise","acquired":false,"shares":13930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 4, 2019, with 13,930 vesting on each of March 4, 2021 and March 4, 2022 and 13,931 vesting on March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 4, 2019, with 13,930 vesting on each of March 4, 2021 and March 4, 2022 and 13,931 vesting on March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":27861,"derivative":{"underlying":"Ordinary Shares","underlying_shares":13930},"source":{"system":"sec-edgar","filing":"0001209191-21-018534","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121018534/doc4.xml","form_type":"4"}},{"id":2804340,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-08T21:12:50.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":13930,"price":10.5661,"value":147185.773,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.510 to $10.690, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2974.39,"source":{"system":"sec-edgar","filing":"0001209191-21-018534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121018534/doc4.xml","form_type":"4"}},{"id":2804339,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-08T21:12:50.000Z","date":"2021-03-04","kind":"exercise","acquired":true,"shares":13930,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":16904.39,"source":{"system":"sec-edgar","filing":"0001209191-21-018534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121018534/doc4.xml","form_type":"4"}},{"id":2823348,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2021-03-02T21:10:01.000Z","date":"2021-02-28","kind":"exercise","acquired":false,"shares":18430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on February 28, 2020 with 18,430 vesting on each of February 28, 2021, February 28, 2022, February 28, 2023 and February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on February 28, 2020 with 18,430 vesting on each of February 28, 2021, February 28, 2022, February 28, 2023 and February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":55290,"derivative":{"underlying":"Ordinary Shares","underlying_shares":18430},"source":{"system":"sec-edgar","filing":"0001209191-21-015861","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121015861/doc4.xml","form_type":"4"}},{"id":2823347,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:10:01.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":18430,"price":10.8308,"value":199611.644,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.78 to $11.01, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2974.39,"source":{"system":"sec-edgar","filing":"0001209191-21-015861","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121015861/doc4.xml","form_type":"4"}},{"id":2823346,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:10:01.000Z","date":"2021-02-28","kind":"exercise","acquired":true,"shares":18430,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":21404.39,"source":{"system":"sec-edgar","filing":"0001209191-21-015861","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121015861/doc4.xml","form_type":"4"}},{"id":2856618,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2021-02-17T21:09:38.000Z","date":"2021-02-14","kind":"exercise","acquired":false,"shares":3926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on February 14, 2017, with 3,926 vesting on each of February 14, 2019, February 14, 2020 and February 14, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on February 14, 2017, with 3,926 vesting on each of February 14, 2019, February 14, 2020 and February 14, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3926},"source":{"system":"sec-edgar","filing":"0001209191-21-011247","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121011247/doc4.xml","form_type":"4"}},{"id":2856617,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2021-02-17T21:09:38.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":3926,"price":11.1229,"value":43668.5054,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.105 to $11.135, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2974.39,"source":{"system":"sec-edgar","filing":"0001209191-21-011247","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121011247/doc4.xml","form_type":"4"}},{"id":2856616,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2021-02-17T21:09:38.000Z","date":"2021-02-14","kind":"exercise","acquired":true,"shares":3926,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":6900.39,"source":{"system":"sec-edgar","filing":"0001209191-21-011247","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121011247/doc4.xml","form_type":"4"}},{"id":2867788,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2021-02-11T21:12:12.000Z","date":"2021-02-09","kind":"grant","acquired":true,"shares":37884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to\ntime-based vesting and will vest on May 11, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to\ntime-based vesting and will vest on May 11, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":37884,"derivative":{"underlying":"Ordinary Shares","underlying_shares":37884},"source":{"system":"sec-edgar","filing":"0001209191-21-009646","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121009646/doc4.xml","form_type":"4"}},{"id":2867787,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2021-02-11T21:12:12.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"shares":12538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on February 9, 2018, with 12,538 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on February 9, 2018, with 12,538 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":12538,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12538},"source":{"system":"sec-edgar","filing":"0001209191-21-009646","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121009646/doc4.xml","form_type":"4"}},{"id":2867786,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2021-02-11T21:12:12.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":52774,"price":12.6945,"value":669939.543,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.635 to $12.785, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2974.39,"source":{"system":"sec-edgar","filing":"0001209191-21-009646","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121009646/doc4.xml","form_type":"4"}},{"id":2867785,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2021-02-11T21:12:12.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":12538,"price":12.6945,"value":159163.641,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.635 to $12.785, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":55748.39,"source":{"system":"sec-edgar","filing":"0001209191-21-009646","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121009646/doc4.xml","form_type":"4"}},{"id":2867784,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2021-02-11T21:12:12.000Z","date":"2021-02-09","kind":"grant","acquired":true,"shares":52774,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents ordinary shares received upon satisfaction of performance- and time-based vesting criteria of performance share units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each performance share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":68286.39,"source":{"system":"sec-edgar","filing":"0001209191-21-009646","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121009646/doc4.xml","form_type":"4"}},{"id":2867783,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2021-02-11T21:12:12.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":12538,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":15512.39,"source":{"system":"sec-edgar","filing":"0001209191-21-009646","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121009646/doc4.xml","form_type":"4"}},{"id":3201339,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2020-03-19T11:38:42.000Z","date":"2020-03-17","kind":"exercise","acquired":false,"shares":2359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 17, 2016, with 2,358 vesting on each of March 17, 2018 and March 17, 2019 and 2,359 vesting on March 17, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 17, 2016, with 2,358 vesting on each of March 17, 2018 and March 17, 2019 and 2,359 vesting on March 17, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2359},"source":{"system":"sec-edgar","filing":"0001209191-20-020166","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120020166/doc4.xml","form_type":"4"}},{"id":3201338,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-19T11:38:42.000Z","date":"2020-03-17","kind":"sale","acquired":false,"shares":2359,"price":7.1635,"value":16898.6965,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.1600 to $7.1850, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2974.39,"source":{"system":"sec-edgar","filing":"0001209191-20-020166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120020166/doc4.xml","form_type":"4"}},{"id":3201337,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-19T11:38:42.000Z","date":"2020-03-17","kind":"exercise","acquired":true,"shares":2359,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":5333.39,"source":{"system":"sec-edgar","filing":"0001209191-20-020166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120020166/doc4.xml","form_type":"4"}},{"id":3235434,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2020-03-03T12:21:35.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":73720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on February 28, 2020 with 18,430 vesting on each of February 28, 2021, February 28, 2022, February 28, 2023 and February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on February 28, 2020 with 18,430 vesting on each of February 28, 2021, February 28, 2022, February 28, 2023 and February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":73720,"derivative":{"underlying":"Ordinary Shares","underlying_shares":73720},"source":{"system":"sec-edgar","filing":"0001209191-20-014856","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120014856/doc4.xml","form_type":"4"}},{"id":3268663,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2020-02-18T12:26:02.000Z","date":"2020-02-14","kind":"exercise","acquired":false,"shares":3926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 14, 2017, with 3,926 vesting on each of February 14, 2019, February 14, 2020 and February 14, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 14, 2017, with 3,926 vesting on each of February 14, 2019, February 14, 2020 and February 14, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":3926,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3926},"source":{"system":"sec-edgar","filing":"0001209191-20-009881","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120009881/doc4.xml","form_type":"4"}},{"id":3268662,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2020-02-18T12:26:02.000Z","date":"2020-02-14","kind":"exercise","acquired":false,"shares":13090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on February 11, 2020 pursuant to the satisfaction of performance criteria and vested on February 14, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on February 11, 2020 pursuant to the satisfaction of performance criteria and vested on February 14, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":13090},"source":{"system":"sec-edgar","filing":"0001209191-20-009881","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120009881/doc4.xml","form_type":"4"}},{"id":3268661,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-18T12:26:02.000Z","date":"2020-02-14","kind":"sale","acquired":false,"shares":3926,"price":12.1422,"value":47670.2772,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.962 to $12.2800, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2974.39,"source":{"system":"sec-edgar","filing":"0001209191-20-009881","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120009881/doc4.xml","form_type":"4"}},{"id":3268660,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-18T12:26:02.000Z","date":"2020-02-14","kind":"sale","acquired":false,"shares":13090,"price":12.1422,"value":158941.398,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.962 to $12.2800, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":6900.39,"source":{"system":"sec-edgar","filing":"0001209191-20-009881","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120009881/doc4.xml","form_type":"4"}},{"id":3268659,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-18T12:26:02.000Z","date":"2020-02-14","kind":"exercise","acquired":true,"shares":3926,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":19990.39,"source":{"system":"sec-edgar","filing":"0001209191-20-009881","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120009881/doc4.xml","form_type":"4"}},{"id":3268658,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-18T12:26:02.000Z","date":"2020-02-14","kind":"exercise","acquired":true,"shares":13090,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":16064.39,"source":{"system":"sec-edgar","filing":"0001209191-20-009881","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120009881/doc4.xml","form_type":"4"}},{"id":3275278,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2020-02-13T12:08:27.000Z","date":"2020-02-11","kind":"grant","acquired":true,"shares":13090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on February 14, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on February 14, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":13090,"derivative":{"underlying":"Ordinary Shares","underlying_shares":13090},"source":{"system":"sec-edgar","filing":"0001209191-20-009052","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120009052/doc4.xml","form_type":"4"}},{"id":3280771,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2020-02-11T12:06:01.000Z","date":"2020-02-09","kind":"exercise","acquired":false,"shares":12538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on February 9, 2018, with 12,538 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on February 9, 2018, with 12,538 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":25076,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12538},"source":{"system":"sec-edgar","filing":"0001209191-20-008169","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120008169/doc4.xml","form_type":"4"}},{"id":3280770,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-11T12:06:01.000Z","date":"2020-02-10","kind":"sale","acquired":false,"shares":12538,"price":12.2405,"value":153471.389,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.2400 to $12.2450, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2974.39,"source":{"system":"sec-edgar","filing":"0001209191-20-008169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120008169/doc4.xml","form_type":"4"}},{"id":3280769,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-11T12:06:01.000Z","date":"2020-02-09","kind":"exercise","acquired":true,"shares":12538,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":15512.39,"source":{"system":"sec-edgar","filing":"0001209191-20-008169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120008169/doc4.xml","form_type":"4"}},{"id":3589268,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2019-03-19T12:11:32.000Z","date":"2019-03-17","kind":"exercise","acquired":false,"shares":2358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 17, 2016, with 2,358 vesting on each of March 17, 2018 and March 17, 2019 and 2,359 vesting on March 17, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 17, 2016, with 2,358 vesting on each of March 17, 2018 and March 17, 2019 and 2,359 vesting on March 17, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":2359,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2358},"source":{"system":"sec-edgar","filing":"0001209191-19-020160","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119020160/doc4.xml","form_type":"4"}},{"id":3589267,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2019-03-19T12:11:32.000Z","date":"2019-03-18","kind":"sale","acquired":false,"shares":2358,"price":16.43,"value":38741.94,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":2974.39,"source":{"system":"sec-edgar","filing":"0001209191-19-020160","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119020160/doc4.xml","form_type":"4"}},{"id":3589266,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2019-03-19T12:11:32.000Z","date":"2019-03-17","kind":"exercise","acquired":true,"shares":2358,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":5332.39,"source":{"system":"sec-edgar","filing":"0001209191-19-020160","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119020160/doc4.xml","form_type":"4"}},{"id":3596262,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2019-03-14T11:44:43.000Z","date":"2019-03-12","kind":"exercise","acquired":false,"shares":2444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 12, 2015, with 2,441 vesting on March 12, 2018 and 2,444 vesting on March 12, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 12, 2015, with 2,441 vesting on March 12, 2018 and 2,444 vesting on March 12, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2444},"source":{"system":"sec-edgar","filing":"0001209191-19-019334","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119019334/doc4.xml","form_type":"4"}},{"id":3596261,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2019-03-14T11:44:43.000Z","date":"2019-03-12","kind":"sale","acquired":false,"shares":2444,"price":15.82,"value":38664.08,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":2974.39,"source":{"system":"sec-edgar","filing":"0001209191-19-019334","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119019334/doc4.xml","form_type":"4"}},{"id":3596260,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2019-03-14T11:44:43.000Z","date":"2019-03-12","kind":"exercise","acquired":true,"shares":2444,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":5418.39,"source":{"system":"sec-edgar","filing":"0001209191-19-019334","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119019334/doc4.xml","form_type":"4"}},{"id":3609963,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2019-03-06T12:30:48.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":41791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on March 4, 2019, with 13,930 vesting on each of March 4, 2021 and March 4, 2022 and 13,931 vesting on March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on March 4, 2019, with 13,930 vesting on each of March 4, 2021 and March 4, 2022 and 13,931 vesting on March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":41791,"derivative":{"underlying":"Ordinary Shares","underlying_shares":41791},"source":{"system":"sec-edgar","filing":"0001209191-19-017237","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119017237/doc4.xml","form_type":"4"}},{"id":3651699,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2019-02-19T12:26:26.000Z","date":"2019-02-14","kind":"exercise","acquired":false,"shares":3926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on February 14, 2017, with 3,926 vesting on each of February 14, 2019, February 14, 2020 and February 14, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on February 14, 2017, with 3,926 vesting on each of February 14, 2019, February 14, 2020 and February 14, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":7852,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3926},"source":{"system":"sec-edgar","filing":"0001209191-19-010841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119010841/doc4.xml","form_type":"4"}},{"id":3651698,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-19T12:26:26.000Z","date":"2019-02-14","kind":"sale","acquired":false,"shares":3926,"price":17.74,"value":69647.24,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":2974.39,"source":{"system":"sec-edgar","filing":"0001209191-19-010841","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119010841/doc4.xml","form_type":"4"}},{"id":3651697,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-19T12:26:26.000Z","date":"2019-02-14","kind":"exercise","acquired":true,"shares":3926,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":6900.39,"source":{"system":"sec-edgar","filing":"0001209191-19-010841","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119010841/doc4.xml","form_type":"4"}},{"id":3988476,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2018-03-20T20:16:31.000Z","date":"2018-03-17","kind":"exercise","acquired":false,"shares":2358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 17, 2016, with 2,358 vesting on each of March 17, 2018 and March 17, 2019 and 2,359 vesting on March 17, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 17, 2016, with 2,358 vesting on each of March 17, 2018 and March 17, 2019 and 2,359 vesting on March 17, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":4717,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2358},"source":{"system":"sec-edgar","filing":"0001209191-18-020867","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118020867/doc4.xml","form_type":"4"}},{"id":3988475,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2018-03-20T20:16:31.000Z","date":"2018-03-19","kind":"sale","acquired":false,"shares":2358,"price":18.38,"value":43340.04,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":2974.39,"source":{"system":"sec-edgar","filing":"0001209191-18-020867","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118020867/doc4.xml","form_type":"4"}},{"id":3988474,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2018-03-20T20:16:31.000Z","date":"2018-03-17","kind":"exercise","acquired":true,"shares":2358,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":5332.39,"source":{"system":"sec-edgar","filing":"0001209191-18-020867","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118020867/doc4.xml","form_type":"4"}},{"id":3997155,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2018-03-14T20:35:50.000Z","date":"2018-03-12","kind":"exercise","acquired":false,"shares":2441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 12, 2015, with 2,441 vesting on March 12, 2018 and 2,444 vesting on March 12, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 12, 2015, with 2,441 vesting on March 12, 2018 and 2,444 vesting on March 12, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":2444,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2441},"source":{"system":"sec-edgar","filing":"0001209191-18-019572","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118019572/doc4.xml","form_type":"4"}},{"id":3997154,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2018-03-14T20:35:50.000Z","date":"2018-03-12","kind":"sale","acquired":false,"shares":2441,"price":19.2,"value":46867.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":2974.39,"source":{"system":"sec-edgar","filing":"0001209191-18-019572","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118019572/doc4.xml","form_type":"4"}},{"id":3997153,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2018-03-14T20:35:50.000Z","date":"2018-03-12","kind":"exercise","acquired":true,"shares":2441,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":5415.39,"source":{"system":"sec-edgar","filing":"0001209191-18-019572","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118019572/doc4.xml","form_type":"4"}},{"id":4067061,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2018-02-12T21:29:27.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":37614,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on February 9, 2018, with 12,538 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on February 9, 2018, with 12,538 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":37614,"derivative":{"underlying":"Ordinary Shares","underlying_shares":37614},"source":{"system":"sec-edgar","filing":"0001209191-18-009210","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118009210/doc4.xml","form_type":"4"}},{"id":4067060,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37708,"kind":"person","name":"Stark David Matthew","position":1,"cik":"0001722360","reported_name":"Stark David Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP Chief Legal Officer"}}],"security":"Stock Options (right to buy)","published_at":"2018-02-12T21:29:27.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":95890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options were granted on February 9, 2018, with 31,963 vesting on each of February 9, 2020 and February 9, 2021 and 31,964 vesting on February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":95890,"derivative":{"exercise_price":18.61,"expiration_date":"2028-02-08","underlying":"Ordinary Shares","underlying_shares":95890},"source":{"system":"sec-edgar","filing":"0001209191-18-009210","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118009210/doc4.xml","form_type":"4"}}]}